Lv4
688 积分 2021-03-03 加入
Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial
2天前
已完结
Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial
24天前
已完结
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
25天前
已完结
Similar Elimination Rates of Glucagon-Like Peptide-1 in Obese Type 2 Diabetic Patients and Healthy Subjects
25天前
已完结
Glucagon-Like Peptide-1 Infusion Must Be Maintained for 24 h/day to Obtain Acceptable Glycemia in Type 2 Diabetic Patients Who Are Poorly Controlled on Sulphonylurea Treatment
25天前
已完结
Flexible eating and flexible insulin dosing in patients with diabetes: Results of an intensive self-management course
1个月前
已完结
Fixed-ratio combination therapy for type 2 diabetes: the top ten things you should know about insulin and glucagon-like peptide-1 receptor agonist combinations
2个月前
已完结
Insulin therapy DE-intensificAtion with iGlarLixi: A phase 4, open-label, parallel-group randomised controlled trial
2个月前
已关闭
2型糖尿病胰岛β细胞功能评估与保护临床专家共识（2026版）
2个月前
已完结
血管痉挛性心绞痛诊断与治疗共识和最新进展[
3个月前
已完结
皖公网安备34019202002308
